Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 2026JCO oncology advances.Open Access

Phase I Dose Escalation and Cohort Expansion of Lorigerlimab, a Bispecific PD-1 × CTLA-4 DART Molecule With Focus on Metastatic Castration-Resistant Prostate Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJason J. LukeMSManish R. SharmaSCSreenivasa R. Chandana

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Luke et al. (2026) studied this question.

synapsesocial.com/papers/6a93ad33744b618ad237e338https://doi.org/10.1200/oa-25-00190
View Full Paper
Ask AI
Bookmark
Share